The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 18, 2025
Filed:
Apr. 19, 2023
Applicant:
Zevra Therapeutics, Inc., Celebration, FL (US);
Inventors:
Sanjib Bera, Blacksburg, VA (US);
Sven Guenther, Coralville, IA (US);
Adam Smith, Orlando, FL (US);
Travis Mickle, Kissimmee, FL (US);
Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/54 (2017.01); A61K 45/06 (2006.01); A61P 25/20 (2006.01); C07C 69/14 (2006.01); C07C 69/88 (2006.01); C07C 69/96 (2006.01); C07C 233/47 (2006.01); C07C 271/64 (2006.01); C07C 271/66 (2006.01); C07C 301/00 (2006.01); C07C 307/02 (2006.01); C07C 307/06 (2006.01); C07C 333/10 (2006.01); C07D 307/20 (2006.01); C07D 407/12 (2006.01); C07F 9/09 (2006.01); C07F 9/24 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/542 (2017.08); A61K 45/06 (2013.01); A61P 25/20 (2018.01); C07C 69/14 (2013.01); C07C 69/88 (2013.01); C07C 69/96 (2013.01); C07C 233/47 (2013.01); C07C 271/64 (2013.01); C07C 271/66 (2013.01); C07C 301/00 (2013.01); C07C 307/02 (2013.01); C07C 307/06 (2013.01); C07C 333/10 (2013.01); C07D 307/20 (2013.01); C07D 407/12 (2013.01); C07F 9/09 (2013.01); C07F 9/2404 (2013.01); C07F 9/2458 (2013.01); A61K 9/0048 (2013.01);
Abstract
Disclosed are one or more compounds comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof). Also disclosed are compositions comprising at least one GHB delivering compound, or a salt thereof, methods of making such compounds, and methods of using such GHB delivering compounds and compositions. Methods of treatment using the compounds are also disclosed.